The human antigen-binding protein (beta)-Klotho, the fibroblast growth factor (FGF) receptor, and its complexes.
Patent Information
- Application Number
- TH2501008820
- Authority / Receiving Office
- TH · TH
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2010-12-03
- Filing Date
- 2010-12-03
- Publication Date
- 2026-04-20
Smart Images

Figure 2501008820_DRAWING_01 
Figure 2501008820_DRAWING_02 
Figure 2501008820_DRAWING_03
Abstract
Claims
DEPCT69 1. A modified antibody or fragment of the thing capable of binding to a complex comprising beta-klotho and fibroblast growth factor receptor 1c (FGFR1c), and inducing fibroblast growth factor 21 (FGF21) signaling, in which such modified antibody or fragment of the thing comprises: an amino acid sequence that is 90% identical to SEQ ID NO: 50 and comprises an amino acid sequence that is 90% identical to SEQ ID NO:
68.
2. A modified antibody or fragment of the thing of claim 1, in which such modified antibody Or a fragment of such thing comprises: an amino acid sequence that is 95% identical to SEQ ID NO: 50 and comprises an amino acid sequence that is 95% identical to SEQ ID NO:
68.
3. A modified antibody or fragment of such thing of Claim 2, where the modified antibody or fragment of such thing comprises SEQ ID: 50 and SEQ ID:
68. 4.A pharmaceutical component consisting of a modified antibody or fragment of that of any one of the claims of claims 1 through 3 in an admixture with its pharmaceutically acceptable carrier.
